Literature DB >> 33424751

Impact of COVID-19 on Stroke Admissions and the Medical Care System in the Tokyo Metropolitan Area.

Takahiro Ota1, Yoshiaki Shiokawa2, Teruyuki Hirano3.   

Abstract

Aims: This study aimed to assess the number of patients with acute stroke seeking medical emergency care since the declaration of the state of emergency in the COVID-19 pandemic in the Tokyo metropolitan area of Japan.
Methods: In this combined retrospective and prospective multicenter survey, data on the numbers of hospital admissions due to acute ischemic stroke, of large vessel occlusion (LVO) cases, and of reperfusion therapies performed from February to July 2020, restrictions of the medical care system, and comprehensive stroke center (CSC) scale scores were collected in 19 stroke centers in Tokyo.
Results: In the survey period, 3,456 patients were admitted with acute stroke. There was a decrease in the number of admissions (-22%), LVO (-22%), thrombolysis (-6%), and thrombectomy (-23%) during the state of emergency, but the ratio of thrombectomy to LVO cases was not different. The acceptance of acute stroke cases by emergency transport and emergent operations in the central eastern area of Tokyo, was also significantly decreased to <50% and remains <60%. According to CSC scores, each hospital restricted their infrastructure or educational activities according to their medical resources. There was only one stroke case with COVID-19 (thrombectomy case) in all 3,456 patients in this study.
Conclusion: The COVID-19 pandemic had a major impact on stroke care in Tokyo, including stroke admissions and medical care systems, resulting in a significant reduction in thrombolysis and thrombectomy. The extent of the drop may be the result of the number of COVID-19 patients.
Copyright © 2020 Ota, Shiokawa and Hirano.

Entities:  

Keywords:  COVID-19; Tokyo; care system; stroke; thrombectomy

Year:  2020        PMID: 33424751      PMCID: PMC7793774          DOI: 10.3389/fneur.2020.601652

Source DB:  PubMed          Journal:  Front Neurol        ISSN: 1664-2295            Impact factor:   4.003


  6 in total

1.  Impact of Coronavirus Disease 2019 on Time Delay and Functional Outcome of Mechanical Thrombectomy in Tokyo, Japan.

Authors:  Masahiro Katsumata; Takahiro Ota; Junya Kaneko; Hiroyuki Jimbo; Rie Aoki; Shigeta Fujitani; Masahiko Ichijo; Masato Inoue; Keigo Shigeta; Yoshifumi Miyauchi; Yu Sakai; Hideki Arakawa; Yoshinobu Otsuka; Kenichi Ariyada; Yoshiaki Kuroshima; Takahisa Fuse; Yoshiaki Shiokawa; Teruyuki Hirano
Journal:  J Stroke Cerebrovasc Dis       Date:  2021-08-13       Impact factor: 2.136

2.  Implementation of Rehabilitation and Patient Outcomes During the Initial COVID-19 Pandemic.

Authors:  Natsuko Kanazawa; Norihiko Inoue; Takuaki Tani; Koichi Naito; Hiromasa Horiguchi; Kiyohide Fushimi
Journal:  Prog Rehabil Med       Date:  2022-06-24

3.  Impact of the COVID-19 pandemic on emergency admission for patients with stroke: a time series study in Japan.

Authors:  Takuaki Tani; Shinobu Imai; Kiyohide Fushimi
Journal:  Neurol Res Pract       Date:  2021-12-13

4.  Impact of the COVID-19 pandemic's first wave on the care and treatment situation of intravitreal injections in a German metropolitan region.

Authors:  Birthe Stemplewitz; Joel Luethy; Ulrich Schaudig; Marc Schargus; Mau-Thek Eddy; Martin Spitzer; Ulrike Brocks; Julie Kieckhoefel; Christa Schneemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-01-10       Impact factor: 3.535

5.  COVID-19 did not result in increased hospitalization for stroke and transient ischemic attack: A nationwide study.

Authors:  Claus Z Simonsen; Rolf A Blauenfeldt; Jakob N Hedegaard; Christina Kruuse; David Gaist; Troels Wienecke; Boris Modrau; Søren P Johnsen; Grethe Andersen
Journal:  Eur J Neurol       Date:  2022-04-21       Impact factor: 6.288

6.  Japanese Medical Facilities Maintained the Quality of Medical Care for Acute Coronary Syndrome during the First Wave of the Coronavirus Disease 2019 Pandemic in Japan.

Authors:  Koshi Nakamura
Journal:  J Atheroscler Thromb       Date:  2021-06-02       Impact factor: 4.394

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.